With DNA mutations such as those in EGFR and Kirsten rat sarcoma viral oncogene homolog (KRAS) constituting a major percentage of Chinese NSCLC cases, DNA NGS is the first choice for patients who have never undergone genetic testing. Here, EGFR is linked to non-small cell lung carcinoma.